|10th November 2020||Al Kraus||8,000||Exercise of derivative||$3.45||$27,600.00|
|10th November 2020||Al Kraus||8,000||Open or private sale||$8.00||$64,000.00|
|18th August 2020||Edward Raymond Jones||4,000||Exercise of derivative||$3.35||$13,400.00|
|31st July 2020||Kathleen P. Bloch||10,000||Exercise of derivative||$5.60||$56,000.00|
|5th May 2020||Phillip P. Chan||14,100||Exercise of derivative||$9.39||$132,399.00|
|5th May 2020||Vincent Capponi||10,123||Exercise of derivative||$9.26||$93,738.98|
|27th April 2020||Vincent Capponi||10,000||Exercise of derivative||$2.88||$28,750.00|
|27th April 2020||Vincent Capponi||10,000||Open or private sale||$10.00||$100,000.00|
|12th April 2020||Efthymios Deliargyris||140,000||Grant/award etc.||$0.00|
|10th March 2020||Vincent Capponi||4,677||Open or private sale||$6.00||$28,062.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
CytoSorbents Corp. engages in the research and development of blood purification technology. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.